Know the Latest Buprenorphine Option for Opioid Use Disorder

January 1

Another ER buprenorphine injection (Brixadi) for moderate to severe opioid use disorder is now available.

It’s still the partial agonist we know...but has differences from other buprenorphine products (Suboxone, Sublocade, etc).

Brixadi ($1,600/month) costs more than generic options, such as sublingual buprenorphine/naloxone tabs averaging $390/month, but Sublocade ($1,900/month) is similar in price.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote